604 related articles for article (PubMed ID: 17606567)
1. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
4. CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group.
BMJ; 1994 Feb; 308(6926):437-40. PubMed ID: 7907246
[TBL] [Abstract][Full Text] [Related]
5. Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy.
Saulsbury F
Clin Infect Dis; 2001 Feb; 32(3):464-8. PubMed ID: 11170955
[TBL] [Abstract][Full Text] [Related]
6. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
Jacobson MA; French M
AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
[TBL] [Abstract][Full Text] [Related]
7. Update on HIV/AIDS in Thailand.
Ruxrungtham K; Phanuphak P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S1-17. PubMed ID: 11529320
[TBL] [Abstract][Full Text] [Related]
8. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3.
Call SA; Heudebert G; Saag M; Wilcox CM
Am J Gastroenterol; 2000 Nov; 95(11):3142-6. PubMed ID: 11095332
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
del Giudice P; Mary-Krause M; Pradier C; Grabar S; Dellamonica P; Marty P; Gastaut JA; Costagliola D; Rosenthal E;
J Infect Dis; 2002 Nov; 186(9):1366-70. PubMed ID: 12402211
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
Powderly WG
Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic infections: an update.
Furrer H; Fux C
J HIV Ther; 2002 Feb; 7(1):2-7. PubMed ID: 11956497
[TBL] [Abstract][Full Text] [Related]
13. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy].
Borleffs JC; Schneider MM; Hoepelman IM
Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2395-9. PubMed ID: 9864534
[TBL] [Abstract][Full Text] [Related]
14. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
Abgrall S; Rabaud C; Costagliola D;
Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976
[TBL] [Abstract][Full Text] [Related]
16. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: a prospective study from birth to 2 years. Mothers and Infants Cohort Study.
Belman AL; Muenz LR; Marcus JC; Goedert JJ; Landesman S; Rubinstein A; Goodwin S; Durako S; Willoughby A
Pediatrics; 1996 Dec; 98(6 Pt 1):1109-18. PubMed ID: 8951261
[TBL] [Abstract][Full Text] [Related]
17. Current status of opportunistic infections in patients with HIV infection in the era of highly active antiretroviral therapy.
Masur H; Kaplan J
Curr Clin Top Infect Dis; 2001; 21():64-82. PubMed ID: 11572162
[No Abstract] [Full Text] [Related]
18. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
Phillips P; Chan K; Hogg R; Bessuille E; Black W; Talbot J; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2002 Feb; 34(3):371-8. PubMed ID: 11774085
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection.
King MD; Reznik DA; O'Daniels CM; Larsen NM; Osterholt D; Blumberg HM
Clin Infect Dis; 2002 Mar; 34(5):641-8. PubMed ID: 11803508
[TBL] [Abstract][Full Text] [Related]
20. I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections.
Fichtenbaum CJ
Res Initiat Treat Action; 1998 Jul; 4(4):3-7. PubMed ID: 11365645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
